DE602004009030D1 - Phenyltetrazol-Verbindungen - Google Patents

Phenyltetrazol-Verbindungen

Info

Publication number
DE602004009030D1
DE602004009030D1 DE602004009030T DE602004009030T DE602004009030D1 DE 602004009030 D1 DE602004009030 D1 DE 602004009030D1 DE 602004009030 T DE602004009030 T DE 602004009030T DE 602004009030 T DE602004009030 T DE 602004009030T DE 602004009030 D1 DE602004009030 D1 DE 602004009030D1
Authority
DE
Germany
Prior art keywords
phenyltetrazole
connections
angiotensin
antagonists
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004009030T
Other languages
English (en)
Other versions
DE602004009030T2 (de
Inventor
Gabriele Razzetti
Domenico Magrone
Mauro Ercoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dipharma Francis SRL
Original Assignee
Dipharma Francis SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dipharma Francis SRL filed Critical Dipharma Francis SRL
Publication of DE602004009030D1 publication Critical patent/DE602004009030D1/de
Application granted granted Critical
Publication of DE602004009030T2 publication Critical patent/DE602004009030T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE602004009030T 2003-11-28 2004-11-19 Phenyltetrazolverbindungen Active DE602004009030T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20032338 2003-11-28
IT002338A ITMI20032338A1 (it) 2003-11-28 2003-11-28 Composti feniltetrazolici.

Publications (2)

Publication Number Publication Date
DE602004009030D1 true DE602004009030D1 (de) 2007-10-31
DE602004009030T2 DE602004009030T2 (de) 2008-06-12

Family

ID=34611237

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004009030T Active DE602004009030T2 (de) 2003-11-28 2004-11-19 Phenyltetrazolverbindungen

Country Status (9)

Country Link
US (2) US7345072B2 (de)
EP (1) EP1555260B1 (de)
JP (1) JP2005162751A (de)
AT (1) ATE373645T1 (de)
DE (1) DE602004009030T2 (de)
ES (1) ES2273617T3 (de)
IT (1) ITMI20032338A1 (de)
PL (1) PL1555260T3 (de)
PT (1) PT1555260E (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1976926A (zh) * 2004-09-02 2007-06-06 特瓦制药工业有限公司 奥美沙坦酯的制备
DE102004060699A1 (de) * 2004-12-16 2006-06-22 Ratiopharm Gmbh Verfahren zur Herstellung von Candesartan
EP1838681A2 (de) * 2004-12-22 2007-10-03 Enantia, S.L. Zwischenprodukte für die herstellung eines angiotensin-ii-rezeptors und verfahren zur herstellung von valsartan
CN101094850A (zh) 2005-01-03 2007-12-26 特瓦制药工业有限公司 具有较低水平杂质的奥美沙坦酯
US20070117987A1 (en) * 2005-07-05 2007-05-24 Viviana Braude Process for preparing valsartan
EP1816131A1 (de) * 2006-02-06 2007-08-08 KRKA, tovarna zdravil, d.d., Novo mesto Verfahren zur Herstellung von Olmesartan Medoxomil
EA014026B1 (ru) * 2005-07-29 2010-08-30 Крка, Товарна Здравил, Д.Д., Ново Место Способ получения олмесартан медоксомила
WO2007071750A1 (en) * 2005-12-22 2007-06-28 Enantia, S.L. Intermediates and processes for the preparation of valsartan
ES2300175B1 (es) * 2006-02-14 2009-06-08 Inke, S.A. Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo.
ITMI20061848A1 (it) * 2006-09-27 2008-03-28 Dipharma Spa Procedimento per la preparazione di composti feniltetrazolici
SI2176253T1 (sl) * 2007-08-08 2012-02-29 Lek Pharmaceuticals D.D. Postopek priprave ali čiščenja olmesartan medoksomila ali hidrohalidne soli olmesartan medoksomila
MX2011012460A (es) 2009-05-20 2012-04-20 Ranbaxy Lab Ltd Proceso para la preparacion de olmesartan medoxomil.
KR101117128B1 (ko) * 2009-06-02 2012-03-14 한국화학연구원 페닐테트라졸 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 골다공증 또는 비만의 예방 또는 치료용 약학적 조성물
WO2011080684A1 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Process for the preparation of candesartan cilexetil
WO2011092666A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof
CN102675294A (zh) * 2012-05-17 2012-09-19 浙江天宇药业股份有限公司 一种合成氯沙坦及其中间体的方法
CN105001209A (zh) * 2015-06-29 2015-10-28 千辉药业（安徽）有限责任公司 一种厄贝沙坦的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5412102A (en) * 1994-05-27 1995-05-02 Syntex (U.S.A.) Inc. Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid
TW409125B (en) * 1996-04-22 2000-10-21 Novartis Ag Antivirally active heterocyclic azahexane derivatives
ES2257771T3 (es) * 1996-10-28 2006-08-01 Amersham Health As Agentes de contraste.
JP2002145770A (ja) * 2000-08-30 2002-05-22 Sankyo Co Ltd 心不全の予防又は治療のための医薬組成物

Also Published As

Publication number Publication date
ES2273617T1 (es) 2007-05-16
EP1555260A1 (de) 2005-07-20
PT1555260E (pt) 2007-12-04
US7345072B2 (en) 2008-03-18
US20080119657A1 (en) 2008-05-22
US20050119488A1 (en) 2005-06-02
ES2273617T3 (es) 2008-03-16
JP2005162751A (ja) 2005-06-23
EP1555260B1 (de) 2007-09-19
PL1555260T3 (pl) 2008-02-29
ITMI20032338A1 (it) 2005-05-29
ATE373645T1 (de) 2007-10-15
DE602004009030T2 (de) 2008-06-12

Similar Documents

Publication Publication Date Title
DE602004009030D1 (de) Phenyltetrazol-Verbindungen
EA200501333A1 (ru) 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
ATE461188T1 (de) Verstärker von glutamat-rezeptoren
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
CL2013002895A1 (es) Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005).
DE502005009089D1 (de) 1-methyl-3-trifluormethyl-pyrazol-4-carbonsäure-(ortho-phenyl)-anilide und ihre verwendung als fungizid
ATE451381T1 (de) Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
ATE345683T1 (de) Malonsäuerenitril-verbindungen und ihre verwendung als pestizide
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
DE602005013819D1 (de) Pyridincarbonsäureamidderivate zur verwendung als antikrebsmittel
ATE419250T1 (de) 2-cyanopyrrolidincarbonsäureamide als dipeptidylpeptidase-iv-inhibitoren
NO20054185L (no) Methods of radiofluorination of biologically active vectors
DK1501507T3 (da) Tetrahydropyranyl-cyclopentyl-tertrahydropyridopyrindin-modulatorer af kemokin-receptor-aktivitet
EA200700702A1 (ru) Аналоги локсапина и способы их применения
EA200602221A1 (ru) Новое применение пептидных соединений для лечения боли при тригеминальной невралгии
ATE374768T1 (de) Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren
ATE413392T1 (de) Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren
DE60214990D1 (de) Benzolsulfonsäureester-indol-5-yl als 5-ht6 rezeptor-antagonisten
DE60228317D1 (de) N-aryl-n'-arylcycloalkyl-harnstoff als mch antagonisten zur behandlung von fettleibigkeit
MA28698B1 (fr) Dicetopiperazines substituees utilisees comme antagonistes des oxytocines
ATE353878T1 (de) Pyridyloxyalkancarbonsäureamid-derivate verwendbar als fungizide
DE50305374D1 (de) Neue prodrugs von 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(n -2-pyridil-n-2-hydroxycarbonylethyl)-amid, ihre herstellung und ihre verwendung als arzneimittel
DE502006003030D1 (de) Verwendung von inhibitoren des na+/h+ austauschers, subtyp 5 (nhe5) zur gedächtnisverbesserung
ECSP056174A (es) Acidos hidroxamicos utiles en el tratamiento detrastornos hiperproliferativos
NO20060603L (no) Fremgangsmate for fremstillingen av fenyltetrazolderivater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition